Serving India and South East Asia, Groupe Athena has been serving companies abroad in obtaining FDA approval for pharmaceuticals, medical products and devices for export to the USA. Our goal is to ensure each of our clients passes FDA inspection by assisting them from concept through development, with consultation through all the regulatory requirements, filings, and processes to achieve FDA compliance and approval. lt br / gt lt br / gt With offices in India and America, the expert consultants of Groupe Athena are in position to go to American target companies and the regulatory authorities directly, consulting with our clients in the East to serve them completely in providing consultancy services for FDA compliance. Services include providing technical and regulatory consulting for biotechnical products, pharmaceuticals over the counter, prescription and generics , diagnostics, medical equipment, and devices. lt br / gt lt br / gt The FDA inspection process is traditionally complicated, especially for foreign drug and medical companies trying to export to the USA. With broad spectrum consultancy and assistance through this process, our client base can count on reduced risk, follow through on steps necessary for FDA compliance and identifying and solving breaches in compliance. lt br / gt lt br / gt From concept through final approval, Groupe Athena navigates companies through every requirement of the process including pharmaceutical consulting, development, and regulatory compliance to achieve FDA approval and export pharmaceuticals and medical products and equipment to the USA. lt br / gt lt br / gt lt br / gt Services Offered: lt br / gt lt br / gt Analytical QC lt br / gt QA Functions lt br / gt Readiness for Inspections lt br / gt Compliance lt br / gt Validation lt br / gt Clinical Trial Management lt br / gt Regulatory/Legal lt br / gt Preparation of Regulatory Filings IND s/PMA s/NDA s/ANDA s/ Ks etc lt br / gt Compliance Assessments GLP, GMP, GXP lt br / gt Risk Assessments lt br / gt Mock FDA Audits lt br / gt Medical Device Support lt br / gt CMC Support lt br / gt GMP Training lt br / gt Facility Layout Consulting lt br / gt Utilities, Process, IT, Computer, and Cleaning Validation lt br / gt Training
Quote | Groupe Athena Inc (OTCMKTS:GATA)
Last: | $0.025 |
---|---|
Change Percent: | 5.04% |
Open: | $0.0186 |
Close: | $0.025 |
High: | $0.04 |
Low: | $0.0186 |
Volume: | 1,976,071 |
Last Trade Date Time: | 07/27/2020 04:54:33 pm |
News | Groupe Athena Inc (OTCMKTS:GATA)
Groupe Athena ( OTCPK:GATA ): Q1 GAAP EPS of $0.02. Revenue of $10.21M (-48.6% Y/Y) Press Release More news on: Groupe Athena Inc., Earnings news and commentary, Consumer stocks news, ,
Mumbai, India, Nov. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Groupe Athena, Inc. (Pink sheets GATA) announced today revenues of $10,211,529 for the period ending September 30, 2018. Operating income before Depreciation and Amortization was $1,480,511 and reflects a Rese...
Message Board Posts | Groupe Athena Inc (OTCMKTS:GATA)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Groupe Athena Inc Company Name:
GATA Stock Symbol:
OTCMKTS Market:
Mumbai, India, Nov. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Groupe Athena, Inc. (Pink sheets GATA) announced today revenues of $10,211,529 for the period ending September 30, 2018. Operating income before Depreciation and Amortization was $1,480,511 and reflects a Rese...
Mumbai, India, July 17, 2018 (GLOBE NEWSWIRE) -- Groupe Athena, Inc. (Pink sheets GATA.PK) is very excited to post the results for their fiscal year ending June 30, 2018. Annual revenue for the period was $55,968,325. EBITDA for the year was also strong at $8,067,798 and net after tax incom...
Mumbai, India, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Groupe Athena, Inc. (OTC PINK: GATA ) announced today revenues of $16,364,908 for the period ending December 31, 2017, an increase of $578,619 over the same period in 2016. Operating income before Depreciation and Amortiza...